QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)

Elanco Animal Health Stock Price, News & Analysis (NYSE:ELAT)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$19.13
▼
$21.51
50-Day Range
$18.43
▼
$21.82
52-Week Range
$17.98
▼
$45.08
Volume
1.12 million shs
Average Volume
97,600 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
11.73%
Price Target
N/A


ELAT Stock News Headlines

December 7, 2023 | markets.businessinsider.com
Analyst Expectations for Elanco Animal Health's Future
November 7, 2023 | msn.com
Fur-casting Success: Elanco Animal Health Tails Ahead with Raised Revenue Outlook, Stock Soars
December 7, 2023 | Autonomix (Ad)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
October 3, 2023 | thestreet.com
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
September 5, 2023 | benzinga.com
Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 15, 2023 | msn.com
Piper Sandler Maintains Elanco Animal Health (ELAN) Neutral Recommendation
August 7, 2023 | msn.com
Elanco spikes as Farm Animal sales drive Q2 revenue beat
August 7, 2023 | msn.com
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Top Estimates
December 7, 2023 | Autonomix (Ad)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
July 14, 2023 | markets.businessinsider.com
Barclays Remains a Buy on Elanco Animal Health (ELAN)
July 13, 2023 | msn.com
Elanco says EPA affirms safety profile of its Seresto flea and tick collars
May 9, 2023 | msn.com
Elanco Animal Health Incorporated (ELAN) Q1 Earnings and Revenues Beat Estimates
May 2, 2023 | seekingalpha.com
Elanco Animal Health cat anemia drug wins FDA approval
April 16, 2023 | marketwatch.com
Elanco Animal Health Inc $ELAN Trading Signals
March 27, 2023 | marketwatch.com
Elanco Animal Health Inc ($ELAN) Trading Report
March 10, 2023 | finance.yahoo.com
Elanco Animal Health Incorporat (ELAT)
February 25, 2023 | seekingalpha.com
Elanco 2022 Earnings: Speculative Value With Signs Of Progress
February 21, 2023 | benzinga.com
Elanco Animal Health shares are trading lower after the company reported Q4 earnings results and issued FY23 adjusted EPS guidance below estimates.
February 21, 2023 | yahoo.com
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
January 22, 2023 | yahoo.com
Elanco Animal Health (NYSE:ELAN) investors are sitting on a loss of 58% if they invested three years ago
January 15, 2023 | morningstar.com
Elanco Animal Health Inc Units ( Purchase Contract & Senior Amortizing Note ELAT Stock Quote
January 3, 2023 | finance.yahoo.com
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference
November 16, 2022 | finance.yahoo.com
Elanco to Participate in Evercore ISI 5th Annual HealthCONx Conference
November 9, 2022 | msn.com
Where Elanco Animal Health Stands With Analysts
November 8, 2022 | msn.com
Elanco Animal Health Inc. (ELAN) Q3 2022 Earnings Call Transcript
November 8, 2022 | seekingalpha.com
Elanco Animal Health Incorporated (ELAN) Q3 2022 Earnings Call Transcript
November 1, 2022 | msn.com
Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
See More Headlines
Receive ELAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Agricultural Commodities/Milling
Sub-Industry
N/A
Sector
Process Industries
Current Symbol
NYSE:ELAT
CUSIP
N/A
CIK
1739104
Web
www.elanco.com
Phone
18773526261
Fax
N/A
Employees
10,200
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$4.54 billion
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report














ELAT Stock Analysis - Frequently Asked Questions

How often does Elanco Animal Health pay dividends? What is the dividend yield for Elanco Animal Health?

Elanco Animal Health announced a quarterly dividend on Thursday, December 8th. Shareholders of record on Friday, January 13th will be paid a dividend of $0.625 per share on Wednesday, February 1st. This represents a $2.50 annualized dividend and a yield of 11.73%. The ex-dividend date is Thursday, January 12th.
Read our dividend analysis for ELAT.

Is Elanco Animal Health a good dividend stock?

Elanco Animal Health (NYSE:ELAT) pays an annual dividend of $2.50 per share and currently has a dividend yield of 4.81%. ELAT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for ELAT.

Who are Elanco Animal Health's major shareholders?

Elanco Animal Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

This page (NYSE:ELAT) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -